Dr. Caughey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
275 Sandwich St
Plymouth, MA 02360Phone+1 508-830-2390Fax+1 508-830-2399
Summary
- Dr. Thomas Caughey is a hematologist/oncologist in Plymouth, MA and is affiliated with Beth Israel Deaconess Plymouth. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 23 years. He is experienced in multiple myeloma and lymphoma.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1998 - 2001
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Certifications & Licensure
- MA State Medical License 2001 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Cancer Associated Thrombosis and Isoquercetin (CATIQ) Start of enrollment: 2015 Jan 01
Publications & Presentations
PubMed
- 49 citationsAdherence to oral chemotherapy: Challenges and opportunities.Susan A. Krikorian, Susan E. Pories, Gary Tataronis, Thomas Caughey, Kirsten Chervinsky
Journal of Oncology Pharmacy Practice. 2019-10-01 - 105 citationsTargeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancerJeffrey I. Zwicker, Benjamin L. Schlechter, Jack D. Stopa, Howard A. Liebman, Anita Aggarwal
JCI Insight. 2019-02-21 - 114 citationsPrediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase...Jeffrey I. Zwicker, Howard A. Liebman, Kenneth A. Bauer, Thomas Caughey, Federico Campigotto
British Journal of Haematology. 2013-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: